Publication Venue For
Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.
A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
No effects of black tea on cognitive decline among older US men: A prospective cohort study.
White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
Primary progressive speech abulia.
Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.
In vivo and in vitro effects of an apolipoprotein E mimetic peptide on amyloid-β pathology.
Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of alzheimer's disease.
Anti-amyloid-β single-chain antibody brain delivery via aav reduces amyloid load but may increase cerebral hemorrhages in an alzheimer's disease mouse model.
Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease.
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
Lesion-induced hippocampal plasticity in transgenic alzheimer's disease mouse models: Influences of age, genotype, and estrogen.
Distractibility and Alzheimer disease: The "neglected" phenomenon.